Schizophrenia News and Research

Latest Schizophrenia News and Research

Suicidal behaviour in schizophrenia may herald future violence

People with schizophrenia who threaten or attempt suicide have a propensity towards violence, UK researchers believe.

11 Mar 2014

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

ValueOptions, Inc. a health improvement company specializing in mental and emotional well-being and recovery, and Genomind, a personalized medicine company, today announced an innovative study that uses pharmacogenomic testing to treat patients diagnosed with psychotic disorders, including schizophrenia and bipolar disorder.

11 Mar 2014

Administration reverses course on proposed Medicare drug changes

After advancing a number of changes to the Medicare Part D program earlier this year, the Centers for Medicare & Medicaid Services withdrew its plan, which had drawn significant opposition from patients, drug companies and lawmakers in both parties.

11 Mar 2014

First Edition: March 11, 2014

Today's headlines include reports that the Centers for Medicare & Medicaid Services is stepping back from proposed changes to the Medicare drug program.

11 Mar 2014

FDA accepts Lundbeck's carbamazepine NDA for review

Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.

10 Mar 2014

Decision-making accuracy can be improved by postponing onset of decision

Columbia University Medical Center (CUMC) researchers have found that decision-making accuracy can be improved by postponing the onset of a decision by a mere fraction of a second.

10 Mar 2014

Findings indicate improved knowledge and beliefs about mental health problems

The findings of the survey, which was led by Orygen Youth Health Research Centre, in collaboration with the University of Melbourne, also indicated improved knowledge and beliefs about mental health problems within the community due, in part, to educational campaigns about mental health.

10 Mar 2014

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma. The finding was published in this week's online edition of Oncotarget.

8 Mar 2014

Neurocognition, negative symptom effects in psychotic prodrome clarified

The contribution of neurocognition and negative symptoms to impaired social and role functioning in patients at clinical high risk of psychosis is important enough to warrant targeting both with therapeutic interventions, say researchers.

7 Mar 2014

Neuroscientist hopes to paint fuller picture of minds and bodies in Neuroscape lab

How does an autistic child take in information when he sits in a classroom abuzz with social activity? How long does it take someone with multiple sclerosis, which slows activity in the brain, to process the light bouncing off the windshield while she drives?

7 Mar 2014

Community care helps schizophrenia patients in resource-poor settings

Collaborative care delivered by community health workers can improve outcomes among patients with schizophrenia receiving facility-based case in resource-poor settings, shows a study in The Lancet.

6 Mar 2014

Inflammation and stress combine in bipolar and schizophrenia subtypes

Researchers have found that some individuals with bipolar disorder or schizophrenia have combined stress response and immune dysfunctions.

6 Mar 2014

Alkermes initiates pivotal clinical development program for treatment of MDD

Alkermes plc today announced the initiation of the pivotal clinical development program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).

6 Mar 2014

Research to identify exact mechanisms behind preterm birth and fetal brain injury

An inflammatory protein that triggers a pregnant mouse's immune response to an infection or other disease appears to cause brain injury in her fetus, but not the premature birth that was long believed to be linked with such neurologic damage in both rodents and humans, new Johns Hopkins-led research suggests.

6 Mar 2014

New study uses Lumosity games to detect subtle cognitive impairments in patients with cirrhosis

A new study from the University of Washington has found that performance on Lumosity games can distinguish between patients with cirrhosis of the liver, pre-cirrhotic patients, and healthy controls. The study used Lumosity games as psychometric tests to detect subtle cognitive impairments in patients with cirrhosis. The study is published in the March issue of the American Journal of Gastroenterology.

6 Mar 2014

Drug abuse does not always lead to psychosis readmission

Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.

5 Mar 2014

Cancer contributes to schizophrenia mortality

Study findings confirm the increased risk of death from physical diseases among patients with schizophrenia, and reveal cancer mortality as an issue among middle-aged patients.

4 Mar 2014

Omeros submits investigational new drug to initiate OMS721 Phase 2 clinical program

Omeros Corporation today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin‑associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.

4 Mar 2014

New uses of imaging technologies could help scientists uncover brain's mysteries

Combining two imagine technologies, such as MRI for structure and MEG for activity, could provide a new understanding of our how our brain works.

4 Mar 2014

Leicester researchers share latest findings on brain research

Although our minds have unravelled many of the mysteries of the world, there is still a lot we don't know about the human brain itself.

4 Mar 2014

Schizophrenia News and Research

Latest Schizophrenia News and Research

Suicidal behaviour in schizophrenia may herald future violence

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

Administration reverses course on proposed Medicare drug changes

First Edition: March 11, 2014

FDA accepts Lundbeck's carbamazepine NDA for review

Decision-making accuracy can be improved by postponing onset of decision

Findings indicate improved knowledge and beliefs about mental health problems

FDA-approved anti-psychotic drugs possess tumor-killing activity against glioblastoma

Neurocognition, negative symptom effects in psychotic prodrome clarified

Neuroscientist hopes to paint fuller picture of minds and bodies in Neuroscape lab

Community care helps schizophrenia patients in resource-poor settings

Inflammation and stress combine in bipolar and schizophrenia subtypes

Alkermes initiates pivotal clinical development program for treatment of MDD

Research to identify exact mechanisms behind preterm birth and fetal brain injury

New study uses Lumosity games to detect subtle cognitive impairments in patients with cirrhosis

Drug abuse does not always lead to psychosis readmission

Cancer contributes to schizophrenia mortality

Omeros submits investigational new drug to initiate OMS721 Phase 2 clinical program

New uses of imaging technologies could help scientists uncover brain's mysteries

Leicester researchers share latest findings on brain research

Forensics and toxicology - Industry Focus eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Forensics and toxicology - Industry Focus eBook eBook

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in